Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Facebook    FB

FACEBOOK

(FB)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

J&J CEO spurns U.S. congressional hearing on carcinogens in talc products

share with twitter share with LinkedIn share with facebook
share via e-mail
0
12/09/2019 | 07:42pm EST
FILE PHOTO: Alex Gorsky, Chairman and CEO of Johnson & Johnson, celebrates the 75th anniversary of his company's listing on the floor at the NYSE in New York

Johnson & Johnson Chief Executive Officer Alex Gorsky has declined to appear at a U.S. congressional hearing set for Tuesday on the safety of the company's Baby Powder and other talc-based cosmetics.

In an announcement, the House of Representatives Subcommittee on Economic and Consumer Policy said that its efforts to persuade Gorsky to testify included "repeated attempts to accommodate the company" over nearly a month.

Democrat Raja Krishnamoorthi, chairman of the House panel investigating concerns about cancer-causing asbestos in cosmetic talc and powders, said he was disappointed Gorsky turned down the invitation.

"Mr. Gorsky refuses to speak to the Subcommittee under oath, yet he has not refrained from making multiple public comments on the topic," Krishnamoorthi said in a statement.

J&J spokesman Ernie Knewitz said that the subcommittee had rejected the company's offers to send a talc testing expert or a J&J executive in charge of consumer products.

Gorsky "is not, as we have repeatedly told the Subcommittee, an expert in the stated subject of the hearing," Knewitz said. "We have respectfully declined the invitation for our CEO to testify."

Knewitz said that the composition of the hearing, which includes two experts who have testified for plaintiffs against J&J, also factored into the company's decision.

Gorsky has played a lead role in J&J's efforts to reassure consumers and investors that its talc powders are safe and asbestos free. Last year, he issued a statement vouching for the safety of the products after a jury issued a $4.69 billion verdict in favour of 22 women who sued over allegations their ovarian cancers were caused by J&J powders.

Gorsky appeared on CNBC's "Mad Money with Jim Cramer" and in a video posted on J&J's website to rebut a December 2018 Reuters report https://www.reuters.com/investigates/special-report/johnsonandjohnson-cancer that the company knew for decades about the presence of small amounts of asbestos in its talc and powders.

"Since tests for asbestos in talc were first developed, J&J's Baby Powder has never contained asbestos," Gorsky said in the video. 

In October, Gorsky testified in a deposition https://www.reuters.com/article/us-johnson-johnson-talc-ceo-insight/johnson-johnson-ceo-testified-baby-powder-was-safe-13-days-before-fda-bombshell-idUSKBN1X12GF in a lawsuit filed by an Indiana man, saying, "We unequivocally believe that our talc and our baby powder does not contain asbestos." J&J faces more than 16,000 similar lawsuits.

Concerns over asbestos in talc cosmetics have grown in recent months as the U.S. Food and Drug Administration announced that the carcinogen had been found in several products, including a bottle of Baby Powder.

J&J said it recalled 33,000 bottles of Baby Powder "out of an abundance of caution." Later, J&J said labs it hired found no asbestos - other than some contamination it blamed on an air conditioner - in samples from the same Baby Powder bottle and its production lot.

The FDA has said it stands by its finding.

Chief executives of companies embroiled in controversies routinely comply with lawmakers' invitations to testify.

In recent months, the CEOs of Boeing and Facebook have appeared before congressional committees to answer questions about how their companies were safeguarding consumers.

Charles M. Elson, director of the John L. Weinberg Center for Corporate Governance at the University of Delaware, said CEOs have a responsibility to go to Washington when Congress calls, just like other citizens.

But Elson said Gorsky's pass was understandable. He said the CEO and his advisers probably figured that the downside was greater to testifying than not.

"It's being invited in for a punch in the nose," Elson said. For Gorsky, "nothing good will come out of it."

(Reporting by Lisa Girion in Los Angeles and Carl O'Donnell in New York; additional reporting by Chad Terhune; editing by Grant McCool and Rosalba O'Brien)

By Lisa Girion and Carl O'Donnell

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on FACEBOOK
03:06aItaly watchdog launches non-compliance proceedings against Facebook
RE
02:43aEXPLAINER : Central bank digital currencies: Moving towards reality?
RE
02:41aUnderperforming Euro auto shares reflect fear of new front in U.S. trade wars
RE
01/23MORE CENTRAL BANKS LOOK TO ISSUE OWN : Bis
RE
01/23Kotex Decides Women's Blood Is Red, Not Blue
DJ
01/23Central Banks Warm to Issuing Digital Currencies
DJ
01/23Amazon's Video Library Has Grown Big on Amateur Content
DJ
01/23195;rsted A/S Ørsted To Present Full-year 2019 Results On 30 January
DJ
01/23YOUNGER WORKERS FEEL LONELY AT THE O : Survey
DJ
01/23United States cautions Britain over Huawei
RE
More news
Financials (USD)
Sales 2019 70 487 M
EBIT 2019 24 603 M
Net income 2019 18 453 M
Finance 2019 52 381 M
Yield 2019 -
P/E ratio 2019 34,6x
P/E ratio 2020 24,3x
EV / Sales2019 8,15x
EV / Sales2020 6,51x
Capitalization 627 B
Chart FACEBOOK
Duration : Period :
Facebook Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends FACEBOOK
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 52
Average target price 243,13  $
Last Close Price 219,76  $
Spread / Highest target 36,5%
Spread / Average Target 10,6%
Spread / Lowest Target -45,4%
EPS Revisions
Managers
NameTitle
Mark Elliot Zuckerberg Chairman & Chief Executive Officer
Sheryl Kara Sandberg Chief Operating Officer & Director
David M. Wehner Chief Financial Officer
Michael Todd Schroepfer Chief Technology Officer
Atish Banerjea Chief Information Officer
Sector and Competitors
1st jan.Capitalization (M$)
FACEBOOK7.07%626 700
TWITTER5.74%26 260
MATCH GROUP, INC.7.75%24 769
LINE CORPORATION0.19%11 750
SINA CORPORATION3.26%2 843
NEW WORK SE1.03%1 830